Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteers.


Journal

Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369

Informations de publication

Date de publication:
02 2020
Historique:
received: 09 12 2019
accepted: 13 12 2019
entrez: 29 1 2020
pubmed: 29 1 2020
medline: 24 10 2020
Statut: ppublish

Résumé

A pilot study was conducted aiming at specifying sultiame's pharmacokinetic profile, completed by in vitro assays evaluating the intraerythrocytic transfer of sultiame and by a pharmacokinetic model assessing its distribution. Single oral doses of sultiame (Ospolot

Identifiants

pubmed: 31990440
doi: 10.1002/prp2.558
pmc: PMC6986439
doi:

Substances chimiques

Thiazines 0
sulthiame I00Q766CZ2

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00558

Informations de copyright

© 2020 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.

Références

Ther Drug Monit. 1994 Jun;16(3):251-7
pubmed: 7916169
Bioorg Med Chem Lett. 2007 Sep 1;17(17):4866-72
pubmed: 17588751
Epilepsy Behav. 2010 Nov;19(3):197-203
pubmed: 20797913
Biochem Soc Trans. 1990 Apr;18(2):171-5
pubmed: 2116334
J Pharmacokinet Pharmacodyn. 2006 Oct;33(5):543-70
pubmed: 16946998
Br J Haematol. 1995 Apr;89(4):748-56
pubmed: 7772511
Seizure. 2018 Mar;56:115-120
pubmed: 29475094
Pharmacol Res Perspect. 2020 Feb;8(1):e00558
pubmed: 31990440
Clin Pharmacokinet. 1995 Nov;29(5):341-69
pubmed: 8582119
Chem Pharm Bull (Tokyo). 1989 Jul;37(7):1913-5
pubmed: 2805171
Br J Clin Pharmacol. 1996 Nov;42(5):605-13
pubmed: 8951192
J Pharm Pharmacol. 1998 Jun;50(6):693-701
pubmed: 9680083
Chem Pharm Bull (Tokyo). 1989 Oct;37(10):2807-10
pubmed: 2611942
Seizure. 2010 Oct;19(8):501-6
pubmed: 20688544
Epilepsia. 2002 May;43(5):469-74
pubmed: 12027906
J Pharmacokinet Pharmacodyn. 2008 Aug;35(4):401-21
pubmed: 18686017
Drugs R D. 2016 Dec;16(4):303-316
pubmed: 27766590

Auteurs

Kim Dao (K)

Service of Clinical Pharmacology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Paul Thoueille (P)

Service of Clinical Pharmacology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Laurent A Decosterd (LA)

Service of Clinical Pharmacology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Thomas Mercier (T)

Service of Clinical Pharmacology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Monia Guidi (M)

Service of Clinical Pharmacology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
School of Pharmaceutical Sciences, Institute of Pharmaceutical Sciences of western Switzerland, Geneva, Switzerland.

Carine Bardinet (C)

Service of Clinical Pharmacology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Sébastien Lebon (S)

Unit of Paediatric Neurology and Neurorehabilitation, Department Mother-Woman-Child, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Eva Choong (E)

Service of Clinical Pharmacology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Arnaud Castang (A)

Advicenne Pharma SA, Nîmes, France.

Catherine Guittet (C)

Advicenne Pharma SA, Nîmes, France.

Luc-André Granier (LA)

Advicenne Pharma SA, Nîmes, France.

Thierry Buclin (T)

Service of Clinical Pharmacology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH